End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.2 TWD | +0.53% | +3.81% | -15.51% |
Mar. 19 | Sinew Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sinew Pharma Inc.(TPEX:6634) added to S&P Global BMI Index | CI |
Sales 2022 | 0.33 10.59 | Sales 2023 | - | Capitalization | 4.8B 155B |
---|---|---|---|---|---|
Net income 2022 | -140M -4.52B | Net income 2023 | -171M -5.52B | EV / Sales 2022 | 18,117,189,024 x |
Net cash position 2022 | 1.38B 44.67B | Net cash position 2023 | 1.27B 40.88B | EV / Sales 2023 | - |
P/E ratio 2022 |
-51.9
x | P/E ratio 2023 |
-27.9
x | Employees | 52 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +0.53% | ||
1 week | +3.81% | ||
Current month | -0.52% | ||
1 month | -1.04% | ||
3 months | -15.88% | ||
6 months | -18.29% | ||
Current year | -15.51% |
Managers | Title | Age | Since |
---|---|---|---|
Kai Min Zhu
CEO | Chief Executive Officer | - | 14-06-17 |
Tzu Wen Chen
DFI | Director of Finance/CFO | - | - |
Cheng Hui Hsiung
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Chuan Chen
BRD | Director/Board Member | - | - |
Li Chun Han
BRD | Director/Board Member | 66 | 19-06-26 |
Tu Mu Kuo
BRD | Director/Board Member | - | 19-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 57.2 | +0.53% | 237 592 |
24-05-20 | 56.9 | -0.18% | 63,636 |
24-05-17 | 57 | +1.06% | 132,648 |
24-05-16 | 56.4 | +4.64% | 206,415 |
24-05-15 | 53.9 | -2.53% | 84,048 |
End-of-day quote Taipei Exchange, May 20, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-15.51% | 125M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- 6634 Stock